Company Filing History:
2 out of 1,440 
2 out of 2,123 
Years Active: 2016-2018
Title: The Innovative Contributions of Erika Pfeiler
Introduction
Erika Pfeiler is a notable inventor based in Greeneville, TN (US). She has made significant contributions to the field of biotechnology, particularly in the area of inflammatory disorders. With a total of 2 patents, her work focuses on innovative methods and compositions that aim to improve health outcomes.
Latest Patents
Erika Pfeiler's latest patents include groundbreaking research on Lactobacillus with decreased lipoteichoic acid to reduce inflammatory responses. These patents provide methods and compositions for treating or preventing inflammatory disorders. The compositions consist of a recombinant bacterium that is genetically modified to decrease the display of lipoteichoic acid on the cell surface. The methods involve administering this recombinant bacterium to a subject, promoting a desired therapeutic response. This innovative approach may be administered in a single dose or a series of doses. The methods find application in treating or preventing various inflammatory disorders, including inflammatory bowel disease, colitis, and Crohn's disease.
Career Highlights
Throughout her career, Erika Pfeiler has worked with esteemed institutions such as North Carolina State University and Northwestern University. Her research has contributed to advancements in the understanding and treatment of inflammatory conditions.
Collaborations
Erika has collaborated with notable professionals in her field, including Todd Robert Klaenhammer and Mansour Mohamadzadeh. These collaborations have further enriched her research and innovations.
Conclusion
Erika Pfeiler's contributions to biotechnology and her innovative patents demonstrate her commitment to improving health through scientific research. Her work continues to pave the way for new treatments for inflammatory disorders.